Endothelial Cell Receptors in Tissue Lipid Uptake and Metabolism

被引:67
作者
Abumrad, Nada A. [1 ]
Cabodevilla, Ainara G. [2 ]
Samovski, Dmitri [1 ]
Pietka, Terri [1 ]
Basu, Debapriya [2 ]
Goldberg, Ira J. [2 ]
机构
[1] Washington Univ, Sch Med, Dept Med, Div Nutr Sci, St Louis, MO 63110 USA
[2] NYU, Dept Med, Div Endocrinol Diabet & Metab, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA
关键词
cardiomyopathy; chylomicrons; fatty acids; lipoprotein; triglyceride; CLASS-B;
D O I
10.1161/CIRCRESAHA.120.318003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipid uptake and metabolism are central to the function of organs such as heart, skeletal muscle, and adipose tissue. Although most heart energy derives from fatty acids (FAs), excess lipid accumulation can cause cardiomyopathy. Similarly, high delivery of cholesterol can initiate coronary artery atherosclerosis. Hearts and arteries-unlike liver and adrenals-have nonfenestrated capillaries and lipid accumulation in both health and disease requires lipid movement from the circulation across the endothelial barrier. This review summarizes recent in vitro and in vivo findings on the importance of endothelial cell receptors and uptake pathways in regulating FAs and cholesterol uptake in normal physiology and cardiovascular disease. We highlight clinical and experimental data on the roles of ECs in lipid supply to tissues, heart, and arterial wall in particular, and how this affects organ metabolism and function. Models of FA uptake into ECs suggest that receptor-mediated uptake predominates at low FA concentrations, such as during fasting, whereas FA uptake during lipolysis of chylomicrons may involve paracellular movement. Similarly, in the setting of an intact arterial endothelial layer, recent and historic data support a role for receptor-mediated processes in the movement of lipoproteins into the subarterial space. We conclude with thoughts on the need to better understand endothelial lipid transfer for fuller comprehension of the pathophysiology of hyperlipidemia, and lipotoxic diseases such as some forms of cardiomyopathy and atherosclerosis.
引用
收藏
页码:433 / 450
页数:18
相关论文
共 206 条
[1]  
Abumrad N, 1998, J LIPID RES, V39, P2309
[2]  
ABUMRAD NA, 1984, J BIOL CHEM, V259, P8945
[3]  
ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665
[4]   CD36 actions in the heart: Lipids, calcium, inflammation, repair and more? [J].
Abumrad, Nada A. ;
Goldberg, Ira J. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2016, 1861 (10) :1442-1449
[5]  
ACTON SL, 1994, J BIOL CHEM, V269, P21003
[6]   Population genetics -: Malaria susceptibility and CD36 mutation [J].
Aitman, TJ ;
Cooper, LD ;
Norsworthy, PJ ;
Wahid, FN ;
Gray, JK ;
Curtis, BR ;
McKeigue, PM ;
Kwiatkowski, D ;
Greenwood, BM ;
Snow, RW ;
Hill, AV ;
Scott, J .
NATURE, 2000, 405 (6790) :1015-1016
[7]   SLC27 fatty acid transport proteins [J].
Anderson, Courtney M. ;
Stahl, Andreas .
MOLECULAR ASPECTS OF MEDICINE, 2013, 34 (2-3) :516-528
[8]   A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis [J].
Armstrong, Susan M. ;
Sugiyama, Michael G. ;
Fung, Karen Y. Y. ;
Gao, Yizhuo ;
Wang, Changsen ;
Levy, Andrew S. ;
Azizi, Paymon ;
Roufaiel, Mark ;
Zhu, Su-Ning ;
Neculai, Dante ;
Yin, Charles ;
Bolz, Steffen-Sebastian ;
Seidah, Nabil G. ;
Cybulsky, Myron I. ;
Heit, Bryan ;
Lee, Warren L. .
CARDIOVASCULAR RESEARCH, 2015, 108 (02) :268-277
[9]   Structure of lipoprotein lipase in complex with GPIHBP1 [J].
Arora, Rishi ;
Nimonkar, Amitabh V. ;
Baird, Daniel ;
Wang, Chunhua ;
Chiu, Chun-Hao ;
Horton, Patricia A. ;
Hanrahan, Susan ;
Cubbon, Rose ;
Weldon, Stephen ;
Tschantz, William R. ;
Mueller, Sascha ;
Brunner, Reto ;
Lehr, Philipp ;
Meier, Peter ;
Ottl, Johannes ;
Voznesensky, Andrei ;
Pandey, Pramod ;
Smith, Thomas M. ;
Stojanovic, Aleksandar ;
Flyer, Alec ;
Benson, Timothy E. ;
Romanowski, Michael J. ;
Trauger, John W. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (21) :10360-10365
[10]   Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling [J].
Assanasen, C ;
Mineo, C ;
Seetharam, D ;
Yuhanna, IS ;
Marcel, YL ;
Connelly, MA ;
Williams, DL ;
de la Llera-Moya, M ;
Shaul, PW ;
Silver, DL .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) :969-977